Novartis

Array shares jump after drugmaker details Novartis deal
Yahoo/AP
Fri, 01/23/15 - 03:27 pm
Array Biopharma
Novartis
encorafenib
binimetinib
cancer
Novartis Fourth-Quarter Profit May Drop: Earnings Preview
WSJ Online
Thu, 01/22/15 - 02:33 pm
Novartis
earnings
Novartis psoriasis drug approval could upend market
Medical Marketing and Media
Thu, 01/22/15 - 09:55 am
Novartis
psoriasis
Cosentyx
Amgen
Stelara
Enbrel
Sandoz gets ready to make the biosimilar case with oncologists
Medical Marketing and Media
Thu, 01/22/15 - 09:51 am
Sandoz
biosimilars
physicians
oncologists
Neupogen
Zarxio
Novartis
FTC Approves Novartis-GSK Deal; Former Asked to Divest Nicotine Patch Business
Bidness Etc.
Thu, 01/22/15 - 09:48 am
FTC
Novartis
GSK
consumer health
nicotine patch
Novartis Wins U.S. Approval for First of New Psoriasis Drugs
Bloomberg
Wed, 01/21/15 - 05:46 pm
Novartis
FDA
psoriasis
Cosentyx
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Novartis to close Puerto Rico plant and outsource to Eli Lilly
In-Pharma Technologist
Mon, 01/19/15 - 04:05 pm
Novartis
Eli Lilly
drug manufacturing
Puerto Rico
Exclusive - More unit IPOs an option for evolving GlaxoSmithKline
Yahoo/Reuters
Fri, 01/16/15 - 10:09 am
IPOs
GSK
Novartis
HIV
Receptos Shopping For A Partner With Strong Data In Hand
Seeking Alpha
Thu, 01/15/15 - 12:05 pm
Receptos
AbbVie
Biogen Idec
JNJ
Novartis
RPC1063
ulcerative colitis
multiple sclerosis
Big Pharma threatens to sue U.K. fund as officials nix Novartis, Sanofi and Eisai meds
Fierce Pharma
Fri, 01/9/15 - 09:58 am
UK
Novartis
Sanofi
Eisai
Roche
Pfizer
Amgen
Is Gilead Sciences Inc. Now a Takeover Target?
Motley Fool
Fri, 01/9/15 - 08:29 am
Gilead Sciences
M&A
Novartis
Pfizer
JNJ
Merck
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Amgen
Regeneron
evolocumab
alirocumab
Alexion
asfotase alfa
Novartis
LCZ696
Pfizer
palbociclib
Novartis Seeks U.S. Approval for Two COPD Drugs
Bloomberg
Thu, 01/8/15 - 08:00 am
Novartis
COPD
QVA149
NVA237
FDA panel recommends approval for first generic biotech drug
Marketwatch
Wed, 01/7/15 - 06:49 pm
FDA
advisory panels
biosimilars
Neupogen
Amgen
Novartis
Sandoz
Novartis moves into genome editing with collaboration deal
Seeking Alpha
Wed, 01/7/15 - 09:26 am
Novartis
genome editing
Intellia Therapeutics
Caribou Biosciences
FDA staff recommends Novartis copy of Amgen's Neupogen
Yahoo/Reuters
Mon, 01/5/15 - 09:29 am
FDA
Amgen
Novartis
Neupogen
biosimilars
breast cancer
Zarzio
chemotheraphy-induced neutropenia
Big pharma waits decision on cancer drugs
FT.com
Sun, 01/4/15 - 10:26 pm
cancer
Roche
JNJ
Novartis
Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:24 pm
Actavis
Celgene
Amgen
AbbVie
Gilead Sciences
Eli Lilly
Novartis
AstraZeneca
Merck
JNJ
Biogen Idec
Novo Nordisk
Roche
Bristol-Myers Squibb
Pfizer
GSK
Sanofi
Cellectis Is Late To The CAR-T Cell Race, But Could Finish First
Seeking Alpha
Fri, 01/2/15 - 07:33 pm
Cellectis
CAR-T
Novartis
GSK
Bellicum
Celgene
Bluebird Bio

Pages